Anti-Muc1 Monoclonal Antibody (C595) and Docetaxel Markedly Reduce Tumor Burden and Ascites, and Prolong Survival in an in Vivo Ovarian Cancer Model

PLoS ONE - United States
doi 10.1371/journal.pone.0024405
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)


Related search